TrialDiabetes, obesity & metabolism2007

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.

M A Nauck et al.PubMed ↗Publisher ↗

No numbers read from the abstract.